The receptor protein tyrosine phosphatase (RPTP)β/ζ is expressed in different subtypes of human breast cancer

Biochemical and Biophysical Research Communications

Volumn 362, Issue 1, 2007, Pages 5-10

  Perez Pinera, Pablo ^a   Garcia Suarez, Olivia ^b,c   Menendez Rodriguez, Primitiva ^b   Mortimer, J ^d   Chang, Y ^a   Astudillo, A ^b,c   Deuel, T F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplastic lymphoma kinase; Breast cancer; Midkine; Pleiotrophin; Receptor protein tyrosine phosphatase (RPTP) ; Tumor progression

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE EPSILON;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INFILTRATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA; CARRIER PROTEINS; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MODELS, BIOLOGICAL; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 34548059562     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.050     Document Type: Article

References (30)

1. Li Y.S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M., Kodner C.M., Milbrandt J., and Deuel T.F. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250 (1990) 1690-1694
2. Deuel T.F., Zhang N., Yeh H.J., Silos-Santiago I., and Wang Z.Y. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch. Biochem. Biophys. 397 (2002) 162-171
3. Vacherot F., Caruelle D., Chopin D., Gil-Diez S., Barritault D., Caruelle J.P., and Courty J. Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate 38 (1999) 126-136
4. Soulie P., Heroult M., Bernard I., Kerros M.E., Milhiet P.E., Delbe J., Barritault D., Caruelle D., and Courty J. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids. J. Immunoassay Immunochem. 23 (2002) 33-48
5. Zhang L., Mabuchi T., Satoh E., Maeda S., Nukui H., and Naganuma H. Overexpression of heparin-binding growth-associated molecule in malignant glioma cells. Neurol. Med.-Chir. (Tokyo) 44 (2004) 637-643 discussion 644-63
6. Wu H., Barusevicius A., Babb J., Klein-Szanto A., Godwin A., Elenitsas R., Gelfand J.M., Lessin S., and Seykora J.T. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J. Cutan. Pathol. 32 (2005) 125-130
7. Souttou B., Juhl H., Hackenbruck J., Rockseisen M., Klomp H.J., Raulais D., Vigny M., and Wellstein A. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J. Natl. Cancer Inst. 90 (1998) 1468-1473
8. Klomp H.J., Zernial O., Flachmann S., Wellstein A., and Juhl H. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin. Cancer Res. 8 (2002) 823-827
9. Jager R., List B., Knabbe C., Souttou B., Raulais D., Zeiler T., Wellstein A., Aigner A., Neubauer A., and Zugmaier G. Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Br. J. Cancer 86 (2002) 858-863
10. Jager R., Noll K., Havemann K., Pfluger K.H., Knabbe C., Rauvala H., and Zugmaier G. Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines. Int. J. Cancer 73 (1997) 537-543
11. Kadomatsu K., and Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 204 (2004) 127-143
12. Garver Jr. R.I., Radford D.M., Donis-Keller H., Wick M.R., and Milner P.G. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74 (1994) 1584-1590
13. Riegel A.T., and Wellstein A. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer. Breast Cancer Res. Treat. 31 (1994) 309-314
14. Wellstein A., Fang W.J., Khatri A., Lu Y., Swain S.S., Dickson R.B., Sasse J., Riegel A.T., and Lippman M.E. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. J. Biol. Chem. 267 (1992) 2582-2587
15. Zhang N., Zhong R., Wang Z.Y., and Deuel T.F. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant. J. Biol. Chem. 272 (1997) 16733-16736
16. Y. Chang, M. Zuka, P. Perez-Pinera, A. Astudillo, J. Mortimer, J.R. Berenson, T.F. Deuel, Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment, Proc. Natl. Acad. Sci. USA 2007. Available online: 19 June 2007. PMID: 17578909.
17. Meng K., Rodriguez-Pena A., Dimitrov T., Chen W., Yamin M., Noda M., and Deuel T.F. Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl. Acad. Sci. USA 97 (2000) 2603-2608
18. Fukada M., Fujikawa A., Chow J.P., Ikematsu S., Sakuma S., and Noda M. Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization. FEBS Lett. (2006)
19. Pariser H., Herradon G., Ezquerra L., Perez-Pinera P., and Deuel T.F. Pleiotrophin regulates serine phosphorylation and the cellular distribution of {beta}-adducin through activation of protein kinase C. Proc. Natl. Acad. Sci. USA 102 (2005) 12407-12412
20. Pariser H., Perez-Pinera P., Ezquerra L., Herradon G., and Deuel T.F. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta. Biochem. Biophys. Res. Commun. 335 (2005) 232-239
21. Pariser H., Ezquerra L., Herradon G., Perez-Pinera P., and Deuel T.F. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: Regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem. Biophys. Res. Commun. 332 (2005) 664-669
22. Kawachi H., Fujikawa A., Maeda N., and Noda M. Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta /beta by the yeast substrate-trapping system. Proc. Natl. Acad. Sci. USA 98 (2001) 6593-6598
23. Tamura H., Fukada M., Fujikawa A., and Noda M. Protein tyrosine phosphatase receptor type Z is involved in hippocampus-dependent memory formation through dephosphorylation at Y1105 on p190 RhoGAP. Neurosci. Lett. (2006)
24. Powers C., Aigner A., Stoica G.E., McDonnell K., and Wellstein A. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J. Biol. Chem. 277 (2002) 14153-14158
25. Bowden E.T., Stoica G.E., and Wellstein A. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J. Biol. Chem. 277 (2002) 35862-35868
26. Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C., Caughey D.J., Wen D., Karavanov A., Riegel A.T., and Wellstein A. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J. Biol. Chem. 276 (2001) 16772-16779
27. Pulford K., Morris S.W., and Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. J. Cell. Physiol. 199 (2004) 330-358
28. Perez-Pinera P., Chang Y., Astudillo A., Mortimer J., and Deuel T.F. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer. Biochem. Biophys. Res. Commun. 358 (2007) 399-403
29. Perez-Pinera P., Garcia-Suarez O., Prieto J.G., Germana A., Ciriaco E., del Valle M.E., and Vega J.A. Thymocyte depletion affects neurotrophin receptor expression in thymic stromal cells. J. Anat. 208 (2006) 231-238
30. Maeda N., Ichihara-Tanaka K., Kimura T., Kadomatsu K., Muramatsu T., and Noda M. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J. Biol. Chem. 274 (1999) 12474-12479